Valuation: Pluri Inc.

Market Cap 13.58M 11.87M 11.15M 10.18M 19.1M 1.3B 19.11M 134M 51.65M 663M 51M 49.88M 2.14B P/E 2025
-1.39x
P/E 2026 -0.85x
Enterprise Value 40.69M 35.56M 33.42M 30.5M 57.24M 3.89B 57.25M 401M 155M 1.99B 153M 149M 6.4B EV / Sales 2025
39,078,124x
EV / Sales 2026 48,878,101x
Free-Float
57.48%
Yield 2025 *
-
Yield 2026 -
1 day-3.64%
1 week-7.02%
Current month-27.89%
1 month-32.05%
3 months-49.40%
6 months-65.36%
Current year-64.55%
1 week 1
Extreme 0.9977
1.16
1 month 1
Extreme 0.9977
1.71
Current year 1
Extreme 0.9977
3.9
1 year 1
Extreme 0.9977
4.86
3 years 1
Extreme 0.9977
8.48
5 years 1
Extreme 0.9977
25.52
10 years 1
Extreme 0.9977
169.6
Manager TitleAgeSince
Chief Executive Officer 54 2017-03-28
Director of Finance/CFO 42 2022-11-30
Chief Operating Officer - 2024-12-31
Director TitleAgeSince
Director/Board Member 54 2015-01-31
Director/Board Member 56 2021-01-05
Director/Board Member 64 2021-05-31
Date Insider Type Main position Quantity % Market Cap. Importance
8/20/26 Free

Director

31,569 0.2926%
8/20/26
Chutzpah Holdings Ltd.
OtherCompany 0 0% -
8/20/26 Free

Director

180,000 1.6683%
Change 5-day change 1-year change 3-year change Capi.($)
-3.64%-7.02%-77.20%-76.77% 13.58M
-0.18%+4.35%+4.23%+30.02% 47.86B
-0.11%+0.54%+44.95%+33.53% 44.46B
-1.51%+4.16%+10.18%+90.44% 41.85B
-0.92%-2.53%+332.01%+547.36% 41.34B
-0.62%-0.06%+10.15%+46.02% 30.04B
-0.46%+1.81%+26.50%+156.49% 17.59B
-4.37%-8.07% - - 15.6B
-3.55%+1.95%+21.97%+39.13% 15.69B
-0.02%+9.69%-8.77% - 13.93B
Average -1.48%+1.76%+40.45%+108.28% 26.84B
Weighted average by Cap. -0.94%+1.88%+68.62%+142.72%

Financials

2025 2026
Net sales 1.34 1.17 1.1 1 1.88 127.72 1.88 13.17 5.08 65.22 5.02 4.91 210.27 1.02 0.89 0.83 0.76 1.43 97.13 1.43 10.02 3.86 49.6 3.82 3.73 159.9
Net income -22.58M -19.74M -18.55M -16.93M -31.77M -2.16B -31.77M -223M -85.9M -1.1B -84.81M -82.95M -3.55B -23.82M -20.82M -19.57M -17.85M -33.51M -2.28B -33.52M -235M -90.61M -1.16B -89.46M -87.5M -3.75B
Net Debt 13.44M 11.74M 11.04M 10.07M 18.9M 1.28B 18.91M 132M 51.11M 656M 50.46M 49.36M 2.11B 27.11M 23.69M 22.27M 20.32M 38.14M 2.59B 38.14M 267M 103M 1.32B 102M 99.58M 4.27B
Logo Pluri Inc.
Pluri Inc., formerly known as Pluristem Therapeutics Inc., is an Israel-headquartered company engaged in the research and provision of cell-based products directed for a range of industries. The Company is focused on researching and developing cell transformation and 3D cell expansion technologies that allow mass production of cells. The products of the Company are used for the pharmaceutical industry as well as for food technology, agriculture technology, and cell-based materials. In the pharmaceutical sector, the Company's preclinical and clinical programs explore multiple therapeutic areas such as vascular disease, inflammation-related conditions, muscle injuries, and hematological disorders. In the food sector, the Firm produces cultivated meat, cultivated fish, and seafood, as well as plant-based products. In agriculture, the Company develops alternative farming methods. The Company has a portfolio of over 140 granted patents in approximately 52 countries.
Employees
103
Date Price Change Volume
26-09-23 $1.060 -3.64% 7,094
26-09-22 $1.100 +2.80% 31,916
26-09-21 $1.070 -0.93% 8,322
26-09-18 $1.080 0.00% 23,831
26-09-17 $1.080 -5.26% 41,594

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. PLUR Stock
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!